<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.investegate.co.uk/~d/styles/itemcontent.css"?><rss xmlns:creativeCommons="http://backend.userland.com/creativeCommonsRssModule" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0"><channel><title>FE Investegate.co.uk Company Announcements</title><link>http://www.investegate.co.uk/rss.aspx</link><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.investegate.co.uk/Investegate" /><description>The UK's latest RNS stories and company announcements</description><language>en</language><image><link>http://www.investegate.co.uk</link><url>http://www.investegate.co.uk/images/ig_logo.png</url><title>FE Investegate.co.uk Company Announcements</title></image><managingEditor>info@investegate.co.uk</managingEditor><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.investegate.co.uk/Investegate" /><feedburner:info uri="investegate" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><creativeCommons:license>http://creativecommons.org/licenses/by/2.0/</creativeCommons:license><feedburner:emailServiceId>Investegate</feedburner:emailServiceId><feedburner:feedburnerHostname>http://feedburner.google.com</feedburner:feedburnerHostname><item><title>Intervest Offices NV : Intervest Offices &amp; Warehouses SA: Result for t...</title><link>http://feeds.investegate.co.uk/~r/Investegate/~3/3lo_W2K20uU/article.aspx</link><guid isPermaLink="false">http://www.investegate.co.uk/article.aspx?id=20120525064634H4771</guid><investegate:headline xmlns:investegate="http://www.investegate.co.uk">Intervest Offices &amp; Warehouses SA: Result for t...</investegate:headline><investegate:company xmlns:investegate="http://www.investegate.co.uk">Intervest Offices NV</investegate:company><investegate:companycode xmlns:investegate="http://www.investegate.co.uk" /><investegate:companylink xmlns:investegate="http://www.investegate.co.uk">index.aspx?company=</investegate:companylink><investegate:datetime xmlns:investegate="http://www.investegate.co.uk">25 May, 2012</investegate:datetime><investegate:time xmlns:investegate="http://www.investegate.co.uk">6:46 AM</investegate:time><investegate:supplier xmlns:investegate="http://www.investegate.co.uk">Thomson Reuters</investegate:supplier><investegate:suppliercode xmlns:investegate="http://www.investegate.co.uk">ONE</investegate:suppliercode><description>6:46 AM:   Intervest Offices &amp; Warehouses SA: Result for t...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.investegate.co.uk/~ff/Investegate?a=3lo_W2K20uU:7-3AeQDVaw4:l6gmwiTKsz0"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Investegate?d=l6gmwiTKsz0" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.investegate.co.uk/~ff/Investegate?a=3lo_W2K20uU:7-3AeQDVaw4:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Investegate?i=3lo_W2K20uU:7-3AeQDVaw4:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.investegate.co.uk/~ff/Investegate?a=3lo_W2K20uU:7-3AeQDVaw4:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Investegate?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.investegate.co.uk/~ff/Investegate?a=3lo_W2K20uU:7-3AeQDVaw4:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Investegate?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Investegate/~4/3lo_W2K20uU" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.investegate.co.uk/article.aspx?id=20120525064634H4771</feedburner:origLink></item><item><title>Solvay S.A. : SOLVAY OPENS A MAJOR INNOVATION CENTRE IN INDIA</title><link>http://feeds.investegate.co.uk/~r/Investegate/~3/vDmn-RbKb7k/article.aspx</link><guid isPermaLink="false">http://www.investegate.co.uk/article.aspx?id=20120525063450H4853</guid><investegate:headline xmlns:investegate="http://www.investegate.co.uk">SOLVAY OPENS A MAJOR INNOVATION CENTRE IN INDIA</investegate:headline><investegate:company xmlns:investegate="http://www.investegate.co.uk">Solvay S.A.</investegate:company><investegate:companycode xmlns:investegate="http://www.investegate.co.uk" /><investegate:companylink xmlns:investegate="http://www.investegate.co.uk">index.aspx?company=</investegate:companylink><investegate:datetime xmlns:investegate="http://www.investegate.co.uk">25 May, 2012</investegate:datetime><investegate:time xmlns:investegate="http://www.investegate.co.uk">6:34 AM</investegate:time><investegate:supplier xmlns:investegate="http://www.investegate.co.uk">Thomson Reuters</investegate:supplier><investegate:suppliercode xmlns:investegate="http://www.investegate.co.uk">ONE</investegate:suppliercode><description>6:34 AM:   SOLVAY OPENS A MAJOR INNOVATION CENTRE IN INDIA&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.investegate.co.uk/~ff/Investegate?a=vDmn-RbKb7k:XAxhqrfsN6g:l6gmwiTKsz0"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Investegate?d=l6gmwiTKsz0" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.investegate.co.uk/~ff/Investegate?a=vDmn-RbKb7k:XAxhqrfsN6g:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Investegate?i=vDmn-RbKb7k:XAxhqrfsN6g:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.investegate.co.uk/~ff/Investegate?a=vDmn-RbKb7k:XAxhqrfsN6g:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Investegate?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.investegate.co.uk/~ff/Investegate?a=vDmn-RbKb7k:XAxhqrfsN6g:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Investegate?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Investegate/~4/vDmn-RbKb7k" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.investegate.co.uk/article.aspx?id=20120525063450H4853</feedburner:origLink></item><item><title>Basilea Pharmaceutica AG : Basilea participates in public-private collabor...</title><link>http://feeds.investegate.co.uk/~r/Investegate/~3/kAs8zeOAo94/article.aspx</link><guid isPermaLink="false">http://www.investegate.co.uk/article.aspx?id=20120525061619H4822</guid><investegate:headline xmlns:investegate="http://www.investegate.co.uk">Basilea participates in public-private collabor...</investegate:headline><investegate:company xmlns:investegate="http://www.investegate.co.uk">Basilea Pharmaceutica AG</investegate:company><investegate:companycode xmlns:investegate="http://www.investegate.co.uk" /><investegate:companylink xmlns:investegate="http://www.investegate.co.uk">index.aspx?company=</investegate:companylink><investegate:datetime xmlns:investegate="http://www.investegate.co.uk">25 May, 2012</investegate:datetime><investegate:time xmlns:investegate="http://www.investegate.co.uk">6:16 AM</investegate:time><investegate:supplier xmlns:investegate="http://www.investegate.co.uk">Thomson Reuters</investegate:supplier><investegate:suppliercode xmlns:investegate="http://www.investegate.co.uk">ONE</investegate:suppliercode><description>6:16 AM:   Basilea participates in public-private collabor...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.investegate.co.uk/~ff/Investegate?a=kAs8zeOAo94:_cr_7HKRhVA:l6gmwiTKsz0"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Investegate?d=l6gmwiTKsz0" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.investegate.co.uk/~ff/Investegate?a=kAs8zeOAo94:_cr_7HKRhVA:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Investegate?i=kAs8zeOAo94:_cr_7HKRhVA:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.investegate.co.uk/~ff/Investegate?a=kAs8zeOAo94:_cr_7HKRhVA:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Investegate?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.investegate.co.uk/~ff/Investegate?a=kAs8zeOAo94:_cr_7HKRhVA:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Investegate?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Investegate/~4/kAs8zeOAo94" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.investegate.co.uk/article.aspx?id=20120525061619H4822</feedburner:origLink></item><item><title>Lifewatch Ag : EANS-Adhoc: Invitation to the Ordinary General ...</title><link>http://feeds.investegate.co.uk/~r/Investegate/~3/E6zlfarZ64U/article.aspx</link><guid isPermaLink="false">http://www.investegate.co.uk/article.aspx?id=20120525055732P0059</guid><investegate:headline xmlns:investegate="http://www.investegate.co.uk">EANS-Adhoc: Invitation to the Ordinary General ...</investegate:headline><investegate:company xmlns:investegate="http://www.investegate.co.uk">Lifewatch Ag</investegate:company><investegate:companycode xmlns:investegate="http://www.investegate.co.uk" /><investegate:companylink xmlns:investegate="http://www.investegate.co.uk">index.aspx?company=</investegate:companylink><investegate:datetime xmlns:investegate="http://www.investegate.co.uk">25 May, 2012</investegate:datetime><investegate:time xmlns:investegate="http://www.investegate.co.uk">5:57 AM</investegate:time><investegate:supplier xmlns:investegate="http://www.investegate.co.uk">PRNewswire</investegate:supplier><investegate:suppliercode xmlns:investegate="http://www.investegate.co.uk">PRN</investegate:suppliercode><description>5:57 AM:   EANS-Adhoc: Invitation to the Ordinary General ...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.investegate.co.uk/~ff/Investegate?a=E6zlfarZ64U:5G7Otl9WXp0:l6gmwiTKsz0"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Investegate?d=l6gmwiTKsz0" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.investegate.co.uk/~ff/Investegate?a=E6zlfarZ64U:5G7Otl9WXp0:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Investegate?i=E6zlfarZ64U:5G7Otl9WXp0:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.investegate.co.uk/~ff/Investegate?a=E6zlfarZ64U:5G7Otl9WXp0:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Investegate?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.investegate.co.uk/~ff/Investegate?a=E6zlfarZ64U:5G7Otl9WXp0:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Investegate?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Investegate/~4/E6zlfarZ64U" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.investegate.co.uk/article.aspx?id=20120525055732P0059</feedburner:origLink></item></channel></rss>

